Bioanalysis

CIR Biopharma's bioanalytical platform is fully functional and equipped to provide complete bioanalytical services. The team has a wide range of precision analytical instruments and equipment such as LC-MS/MS, multi-functional enzyme labeling instrument, fluorescence quantitative PCR instrument, flow cytometer, etc., which allows us to carry out various bioanalytical method development and methodology confirmation, as well as quantitative testing of plasma, serum, tissues, urine, feces and other biological samples. We support drug screening and development and preclinical drugability studies.

Small molecule bioanalysis:

We can provide small molecule drug bioanalytical services, including LC-MS/MS method development and methodology validation, as well as quantitative detection of whole blood, plasma, tissues, urine, feces and other biological samples, to support small molecule drug screening and development. Method validation content: linear range, specificity, accuracy, precision, sensitivity, extraction recovery, matrix effect, stability, etc.

Biomacromolecule bioanalysis:

We can provide large molecule drug bioanalytical services, including ELISA method development and methodological validation and immunogenicity analysis to support the screening and development of protein drugs, antibody drugs, vaccines and biomarkers. Method validation content: linear range, specificity, accuracy, precision, sensitivity, stability, etc.